Diabetes technology & therapeutics
-
Diabetes Technol. Ther. · Dec 2016
NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes.
Accurate and economic detection of nerve damage in diabetes is key to more widespread diagnosis of patients with diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy. This study examined the diagnostic performance of NerveCheck, an inexpensive ($500) quantitative sensory testing (QST) device. ⋯ NerveCheck is a low-cost QST device with good diagnostic utility for identifying sensory deficits, comparable to established tests of large and small fiber neuropathy and for the severity of neuropathic pain.